-
21.发明授权Method of using IL-29 cysteine mutant to treat hepatitis C and hepatitis B 有权使用IL-29半胱氨酸突变体治疗丙型肝炎和乙型肝炎的方法公开(公告)号：US07727518B2
公开(公告)日：2010-06-01
申请号：US12043885
申请日：2008-03-06
申请人： Lowell J. Brady , Kevin M. Klucher , Chung Chan , Dennis L. Dong , Hong Y. Liu , Paul O. Sheppard , Thomas R. Bukowski
发明人： Lowell J. Brady , Kevin M. Klucher , Chung Chan , Dennis L. Dong , Hong Y. Liu , Paul O. Sheppard , Thomas R. Bukowski
CPC分类号： A61K38/20 , A61K38/00 , C07K14/54 , C07K14/555 , C07K2319/00 , Y10S435/81 , Y10S435/975 , Y10S514/894
摘要： Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
摘要翻译： 已经通过在编码成熟蛋白的多核苷酸序列中突变一个或多个半胱氨酸残基来产生IL-28A，IL-28B和IL-29的均质制剂。 可以显示半胱氨酸突变蛋白与其同源受体结合或表现出生物活性。 所示的一种生物活性是抗病毒活性。
-
公开(公告)号：US20100104531A1
公开(公告)日：2010-04-29
申请号：US12572167
申请日：2009-10-01
申请人： Lowell J. Brady , Kevin M. Klucher , Chung Chan , Dennis L. Dong , Hong Y. Liu , Paul O. Sheppard , Thomas R. Bukowski
发明人： Lowell J. Brady , Kevin M. Klucher , Chung Chan , Dennis L. Dong , Hong Y. Liu , Paul O. Sheppard , Thomas R. Bukowski
CPC分类号： A61K38/20 , A61K38/00 , C07K14/54 , C07K14/555 , C07K2319/00 , Y10S435/81 , Y10S435/975 , Y10S514/894
摘要： Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
摘要翻译： 已经通过在编码成熟蛋白的多核苷酸序列中突变一个或多个半胱氨酸残基来产生IL-28A，IL-28B和IL-29的均质制剂。 可以显示半胱氨酸突变蛋白与其同源受体结合或表现出生物活性。 所示的一种生物活性是抗病毒活性。
-
公开(公告)号：US07588918B2
公开(公告)日：2009-09-15
申请号：US11550230
申请日：2006-10-17
申请人： Lowell J. Brady , Kevin M. Klucher , Chung Chan , Dennis L. Dong , Hong Y. Liu , Paul O. Sheppard , Thomas R. Bukowski
发明人： Lowell J. Brady , Kevin M. Klucher , Chung Chan , Dennis L. Dong , Hong Y. Liu , Paul O. Sheppard , Thomas R. Bukowski
CPC分类号： A61K38/20 , A61K38/00 , C07K14/54 , C07K14/555 , C07K2319/00 , Y10S435/81 , Y10S435/975 , Y10S514/894
摘要： Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
-
公开(公告)号：US07582450B2
公开(公告)日：2009-09-01
申请号：US11550208
申请日：2006-10-17
申请人： Lowell J. Brady , Kevin M. Klucher , Chung Chan , Dennis L. Dong , Hong Y. Liu , Paul O. Sheppard , Thomas R. Bukowski
发明人： Lowell J. Brady , Kevin M. Klucher , Chung Chan , Dennis L. Dong , Hong Y. Liu , Paul O. Sheppard , Thomas R. Bukowski
CPC分类号： A61K38/20 , A61K38/00 , C07K14/54 , C07K14/555 , C07K2319/00 , Y10S435/81 , Y10S435/975 , Y10S514/894
摘要： Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
摘要翻译： 已经通过在编码成熟蛋白的多核苷酸序列中突变一个或多个半胱氨酸残基来产生IL-28A，IL-28B和IL-29的均质制剂。 可以显示半胱氨酸突变蛋白与其同源受体结合或表现出生物活性。 所示的一种生物活性是抗病毒活性。
-
公开(公告)号：US07485701B2
公开(公告)日：2009-02-03
申请号：US11549519
申请日：2006-10-13
申请人： Lowell J. Brady , Kevin M. Klucher , Chung Chan , Dennis L. Dong , Hong Y. Liu , Paul O. Sheppard , Thomas R. Bukowski
发明人： Lowell J. Brady , Kevin M. Klucher , Chung Chan , Dennis L. Dong , Hong Y. Liu , Paul O. Sheppard , Thomas R. Bukowski
CPC分类号： A61K38/20 , A61K38/00 , C07K14/54 , C07K14/555 , C07K2319/00 , Y10S435/81 , Y10S435/975 , Y10S514/894
摘要： Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.
-
公开(公告)号：US07563438B2
公开(公告)日：2009-07-21
申请号：US11752197
申请日：2007-05-22
申请人： Theresa A. Deisher , Darrell C. Conklin , Fenella C. Raymond , Thomas R. Bukowski , Susan D. Holderman , Paul O. Sheppard
发明人： Theresa A. Deisher , Darrell C. Conklin , Fenella C. Raymond , Thomas R. Bukowski , Susan D. Holderman , Paul O. Sheppard
IPC分类号： A61K39/395 , C07K16/00 , C07K16/22
CPC分类号： C07K14/50 , A61K38/00 , C07K2319/00
摘要： The present invention relates to antibodies and fragments thereof, polynucleotide and polypeptide molecules for zFGF5 a novel member of the FGF family. The polypeptides, and polynucleotides encoding them, are proliferative for muscle cells, in particular cardiac cells and may be used for remodeling cardiac tissue and improving cardiac function. The present invention also includes antibodies to the zFGF5 polypeptides.
摘要翻译： 本发明涉及抗体及其片段，用于zFGF5的多核苷酸和多肽分子是FGF家族的新成员。 多肽和编码它们的多核苷酸对于肌肉细胞，特别是心脏细胞是增殖性的，并且可以用于重建心脏组织和改善心脏功能。 本发明还包括对zFGF5多肽的抗体。
-
公开(公告)号：US20080233114A1
公开(公告)日：2008-09-25
申请号：US11752197
申请日：2007-05-22
申请人： Theresa A. Deisher , Darrell C. Conklin , Fenella C. Raymond , Thomas R. Bukowski , Susan D. Holderman , Paul O. Sheppard
发明人： Theresa A. Deisher , Darrell C. Conklin , Fenella C. Raymond , Thomas R. Bukowski , Susan D. Holderman , Paul O. Sheppard
IPC分类号： A61K39/395 , C07K16/00 , A61P29/00
CPC分类号： C07K14/50 , A61K38/00 , C07K2319/00
摘要： The present invention relates to polynucleotide and polypeptide molecules for zFGF5 a novel member of the FGF family. The polypeptides, and polynucleotides encoding them, are proliferative for muscle cells, in particular cardiac cells and may be used for remodeling cardiac tissue and improving cardiac function. The present invention also includes antibodies to the zFGF5 polypeptides.
摘要翻译： 本发明涉及zFGF5的多核苷酸和多肽分子，其是FGF家族的新成员。 多肽和编码它们的多核苷酸对于肌肉细胞，特别是心脏细胞是增殖性的，并且可以用于重建心脏组织和改善心脏功能。 本发明还包括对zFGF5多肽的抗体。
-
公开(公告)号：US06352971B1
公开(公告)日：2002-03-05
申请号：US09368951
申请日：1999-08-05
申请人： Theresa A. Deisher , Darrell C. Conklin , Fenella Raymond , Thomas R. Bukowski , Susan D. Holderman , Birgit Hansen , Paul O. Sheppard
发明人： Theresa A. Deisher , Darrell C. Conklin , Fenella Raymond , Thomas R. Bukowski , Susan D. Holderman , Birgit Hansen , Paul O. Sheppard
IPC分类号： A61K3800
CPC分类号： C12N5/0657 , A61K38/00 , A61K47/62 , A61K47/6835 , C07K14/50 , C07K16/22 , C07K2319/00 , C12N2501/119
摘要： The present invention relates to polynucleotide and polypeptide molecules for zFGF-5 a novel member of the FGF family. The polypeptides, and polynucleotides encoding them, are proliferative for muscle cells and may be used for remodelling cardiac tissue and improving cardiac function. The present invention also includes antibodies to the zFGF-5 polypeptides.
摘要翻译： 本发明涉及用于zFGF-5的FGF家族的新成员的多核苷酸和多肽分子。 多肽和编码它们的多核苷酸对于肌肉细胞是增殖性的，并且可以用于重塑心脏组织和改善心脏功能。 本发明还包括对zFGF-5多肽的抗体。
-
公开(公告)号：US07247608B2
公开(公告)日：2007-07-24
申请号：US10037922
申请日：2001-10-19
申请人： Theresa A. Deisher , Darrell C. Conklin , Fenella Raymond , Thomas R. Bukowski , Susan D. Holderman , Birgit Hansen , Paul O. Sheppard
发明人： Theresa A. Deisher , Darrell C. Conklin , Fenella Raymond , Thomas R. Bukowski , Susan D. Holderman , Birgit Hansen , Paul O. Sheppard
CPC分类号： C12N5/0657 , A61K38/00 , A61K47/62 , A61K47/6835 , C07K14/50 , C07K16/22 , C07K2319/00 , C12N2501/119
摘要： The present invention relates to polynucleotide and polypeptide molecules for zFGF-5 a novel member of the FGF family. The polypeptides, and polynucleotides encoding them, are proliferative for muscle cells and may be used for remodelling cardiac tissue and improving cardiac function. The present invention also includes antibodies to the zFGF-5 polypeptides.
摘要翻译： 本发明涉及用于zFGF-5的FGF家族的新成员的多核苷酸和多肽分子。 多肽和编码它们的多核苷酸对于肌肉细胞是增殖性的，并且可以用于重塑心脏组织和改善心脏功能。 本发明还包括对zFGF-5多肽的抗体。
-
公开(公告)号：US5989866A
公开(公告)日：1999-11-23
申请号：US951822
申请日：1997-10-16
申请人： Theresa A. Deisher , Darrell C. Conklin , Fenella Raymond , Thomas R. Bukowski , Susan D. Holderman , Birgit Hansen , Paul O. Sheppard
发明人： Theresa A. Deisher , Darrell C. Conklin , Fenella Raymond , Thomas R. Bukowski , Susan D. Holderman , Birgit Hansen , Paul O. Sheppard
IPC分类号： C12N15/09 , A61K38/00 , A61P9/10 , A61P19/08 , A61P21/00 , C07K14/50 , C07K16/22 , C07K19/00 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/077 , C12N5/10 , C12N15/18 , C12P21/02 , C12P21/08 , C12N5/00 , C12N15/63
CPC分类号： A61K47/48238 , A61K47/48507 , C07K14/50 , C07K16/22 , C12N5/0657 , A61K38/00 , C07K2319/00 , C12N2501/119
摘要： The present invention relates to polynucleotide and polypeptide molecules for zFGF-5 a novel member of the FGF family. The polypeptides, and polynucleotides encoding them, are proliferative for muscle cells and may be used for remodelling cardiac tissue and improving cardiac function. The present invention also includes antibodies to the zFGF-5 polypeptides.
摘要翻译： 本发明涉及用于zFGF-5的FGF家族的新成员的多核苷酸和多肽分子。 多肽和编码它们的多核苷酸对于肌肉细胞是增殖性的，并且可以用于重塑心脏组织和改善心脏功能。 本发明还包括对zFGF-5多肽的抗体。
-
-
-
-
-
-
-
-
-
搜索结果
32 条记录 (耗时 0.043 秒)
